Overview

Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity

Status:
Unknown status

Trial end date:
2018-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to validate the International Warfarin Pharmacogenetics Consortium (IWPC) algorithm in a prospective cohort of elderly people (65 years or older) with heart valves and/or nonvalvular atrial fibrillation (AF) and at least one comorbid condition, and to assess the algorithm's prognostic relevance.

Details

Lead Sponsor:

Second University of Naples
University of Campania "Luigi Vanvitelli"

Collaborators:

Federico II University
University of Salerno

Treatments:

Warfarin